SLC6A3 and attention deficit-hyperactivity disorder: In the case of vLDX, a strong relation of both TAAR1 and DAT (or SLC6A3) modulation for high ADHD-tSignal variation (reaching >50% variation) was observed, suggesting a relevant role of these targets in the vLDX predicted mechanisms to treat ADHD.